Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain

Abstract Altered pain sensations such as hyperalgesia and allodynia are characteristic features of various pain states, and remain difficult to treat. We have shown previously that spinal application of dipeptidyl peptidase 4 (DPP4) inhibitors induces strong antihyperalgesic effect during inflammato...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kornél Király, Márk Kozsurek, Erika Lukácsi, Benjamin Barta, Alán Alpár, Tamás Balázsa, Csaba Fekete, Judit Szabon, Zsuzsanna Helyes, Kata Bölcskei, Valéria Tékus, Zsuzsanna E. Tóth, Károly Pap, Gábor Gerber, Zita Puskár
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/24d74c8afb4446d58b71a3a0eb302c9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:24d74c8afb4446d58b71a3a0eb302c9f
record_format dspace
spelling oai:doaj.org-article:24d74c8afb4446d58b71a3a0eb302c9f2021-12-02T11:41:02ZGlial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain10.1038/s41598-018-21799-82045-2322https://doaj.org/article/24d74c8afb4446d58b71a3a0eb302c9f2018-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-21799-8https://doaj.org/toc/2045-2322Abstract Altered pain sensations such as hyperalgesia and allodynia are characteristic features of various pain states, and remain difficult to treat. We have shown previously that spinal application of dipeptidyl peptidase 4 (DPP4) inhibitors induces strong antihyperalgesic effect during inflammatory pain. In this study we observed low level of DPP4 mRNA in the rat spinal dorsal horn in physiological conditions, which did not change significantly either in carrageenan-induced inflammatory or partial nerve ligation-generated neuropathic states. In naïve animals, microglia and astrocytes expressed DPP4 protein with one and two orders of magnitude higher than neurons, respectively. DPP4 significantly increased in astrocytes during inflammation and in microglia in neuropathy. Intrathecal application of two DPP4 inhibitors tripeptide isoleucin-prolin-isoleucin (IPI) and the antidiabetic drug vildagliptin resulted in robust opioid-dependent antihyperalgesic effect during inflammation, and milder but significant opioid-independent antihyperalgesic action in the neuropathic model. The opioid-mediated antihyperalgesic effect of IPI was exclusively related to mu-opioid receptors, while vildagliptin affected mainly delta-receptor activity, although mu- and kappa-receptors were also involved. None of the inhibitors influenced allodynia. Our results suggest pathology and glia-type specific changes of DPP4 activity in the spinal cord, which contribute to the development and maintenance of hyperalgesia and interact with endogenous opioid systems.Kornél KirályMárk KozsurekErika LukácsiBenjamin BartaAlán AlpárTamás BalázsaCsaba FeketeJudit SzabonZsuzsanna HelyesKata BölcskeiValéria TékusZsuzsanna E. TóthKároly PapGábor GerberZita PuskárNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-15 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kornél Király
Márk Kozsurek
Erika Lukácsi
Benjamin Barta
Alán Alpár
Tamás Balázsa
Csaba Fekete
Judit Szabon
Zsuzsanna Helyes
Kata Bölcskei
Valéria Tékus
Zsuzsanna E. Tóth
Károly Pap
Gábor Gerber
Zita Puskár
Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
description Abstract Altered pain sensations such as hyperalgesia and allodynia are characteristic features of various pain states, and remain difficult to treat. We have shown previously that spinal application of dipeptidyl peptidase 4 (DPP4) inhibitors induces strong antihyperalgesic effect during inflammatory pain. In this study we observed low level of DPP4 mRNA in the rat spinal dorsal horn in physiological conditions, which did not change significantly either in carrageenan-induced inflammatory or partial nerve ligation-generated neuropathic states. In naïve animals, microglia and astrocytes expressed DPP4 protein with one and two orders of magnitude higher than neurons, respectively. DPP4 significantly increased in astrocytes during inflammation and in microglia in neuropathy. Intrathecal application of two DPP4 inhibitors tripeptide isoleucin-prolin-isoleucin (IPI) and the antidiabetic drug vildagliptin resulted in robust opioid-dependent antihyperalgesic effect during inflammation, and milder but significant opioid-independent antihyperalgesic action in the neuropathic model. The opioid-mediated antihyperalgesic effect of IPI was exclusively related to mu-opioid receptors, while vildagliptin affected mainly delta-receptor activity, although mu- and kappa-receptors were also involved. None of the inhibitors influenced allodynia. Our results suggest pathology and glia-type specific changes of DPP4 activity in the spinal cord, which contribute to the development and maintenance of hyperalgesia and interact with endogenous opioid systems.
format article
author Kornél Király
Márk Kozsurek
Erika Lukácsi
Benjamin Barta
Alán Alpár
Tamás Balázsa
Csaba Fekete
Judit Szabon
Zsuzsanna Helyes
Kata Bölcskei
Valéria Tékus
Zsuzsanna E. Tóth
Károly Pap
Gábor Gerber
Zita Puskár
author_facet Kornél Király
Márk Kozsurek
Erika Lukácsi
Benjamin Barta
Alán Alpár
Tamás Balázsa
Csaba Fekete
Judit Szabon
Zsuzsanna Helyes
Kata Bölcskei
Valéria Tékus
Zsuzsanna E. Tóth
Károly Pap
Gábor Gerber
Zita Puskár
author_sort Kornél Király
title Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
title_short Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
title_full Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
title_fullStr Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
title_full_unstemmed Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
title_sort glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/24d74c8afb4446d58b71a3a0eb302c9f
work_keys_str_mv AT kornelkiraly glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT markkozsurek glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT erikalukacsi glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT benjaminbarta glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT alanalpar glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT tamasbalazsa glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT csabafekete glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT juditszabon glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT zsuzsannahelyes glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT katabolcskei glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT valeriatekus glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT zsuzsannaetoth glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT karolypap glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT gaborgerber glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
AT zitapuskar glialcelltypespecificchangesinspinaldipeptidylpeptidase4expressionandeffectsofitsinhibitorsininflammatoryandneuropaticpain
_version_ 1718395449768935424